Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer

Laboratory Investigation

Volumn 81, Issue 2, 2001, Pages 159-165

  Prechtel, Dieter ^a   Harbeck, Nadia ^b   Berger, Ursula ^c   Höfler, Heinz ^a   Werenskiold, Ann Katrin ^a  

^a Inst Allg Pathol Pathologische A   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GLYCOPROTEIN; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID; STEROID RECEPTOR; IMMUNOGLOBULIN; T1 S PROTEIN, HUMAN; T1-S PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; FEMALE; GENE OVEREXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; BREAST TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034745671     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780223     Document Type: Article

References (31)

1. American Cancer Society National Conference on Breast Cancer, Boston, Massachusetts, August 26-28, 1993
2. Current status of grading in breast cancer
3. Alternative promoter usage of the fosresponsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor
4. Steroid receptors and other prognostic factors in primary breast cancer
5. Regression models and life-tables
6. Recent advances in breast cancer biology
7. Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer
8. Cell kinetics in human breast cancer: Comparison between the prognostic value of the cytofluorimetric S phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry
9. Recent advances in breast cancer biology
10. Nonparametric estimation from incomplete observations
11. Serum- and oncoprotein mediated induction of a gene with similarity to carcinoembrionic antigen
12. Expression of ST2, an interleukin-1 receptor homolog, is induced by proinflammatory stimuli
13. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function
14. Prognostic factors and treatment decisions in axillary node negative breast cancer
15. Prognostic factors in breast cancer
16. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients
17. Expression of cell-cycle regulators p27kip1 and cyclinE, alone and in combination, correlation with survival in young breast cancer patients
18. Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers
19. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue
20. T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells
21. Secreted and membrane-bound isoforms of T1, an orphan receptor related to IL-1 binding proteins, are differently expressed in vivo
22. Ki-67 immunostaining in node-negative stageI/II breast carcinoma. Significant correlation with prognosis
23. p53 und bcl-2 expression correlates with clinical outcome in a series of node-negative breast cancer patients
24. TNM Classification of Malignant Tumors, fifth edition (1997)
25. Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer
26. Role of celltype-specific promoters in the developmental regulation of T1, an Interleukin-1 receptor homologue
27. Nucleotide sequence of a complementary DNA for human ST2
28. Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer
29. Bone matrix deposition of T1, a homologue of interleukin 1 receptors
30. Suppression of T1 receptor expression by anti-sense RNA abrogates differentiation of osteogenic osteosarcoma cells
31. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells